Sargon II (reigned 722-705 BCE) was one of the most important kings of the Neo-Assyrian Empire as founder of the Sargonid Dynasty which would rule the empire for the next century until its fall. He was a great military leader, tactician, patron of the arts and culture, and a prolific builder of monuments, temples, and even a city.
Harvoni can be used by people being treated for hepatitis C for the first time (known as âtreatment-naiveâ) and for retreatment of people who were not cured with previous interferon-based therapy (known as âtreatment-experiencedâ). Harvoni has also been tested in people with HIV and HCV co-infection.
Gilead Sciences' Harvoni, a once-daily fixed-dose coformulation containing the nucleotide HCV polymerase inhibitor sofosbuvir and the NS5A replication complex inhibitor ledipasvir, has been approved by the European Commission for the treatment of people with hepatitis C genotypes 1 and 4, the company announced this week.